Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study.
Joly P, Tejedor I, Tetart F, Cailleux HC, Barrel A, De Preville PA, Mion-Mouton N, Gabison G, Baricault S, Tordeur CG, Dore MX, Rossi B, Bourseau-Quetier C, Chamaillard M, Ly S, Chosidow O, Richard-Lallemand MA, Rzeznik JC, Amici JM, Lair G, Bechu S, Benichou J, Thill C, Beylot-Barry M. Joly P, et al. Among authors: barrel a. J Am Acad Dermatol. 2021 May;84(5):1278-1284. doi: 10.1016/j.jaad.2020.09.055. Epub 2020 Sep 30. J Am Acad Dermatol. 2021. PMID: 33010323 Clinical Trial.
Risk factors for treatment failure in scabies: a cohort study.
Aussy A, Houivet E, Hébert V, Colas-Cailleux H, Laaengh N, Richard C, Ouvry M, Boulard C, Léger S, Litrowski N, Benichou J, Joly P; investigators from the Normandy Association of Medical Education in Dermatology. Aussy A, et al. Br J Dermatol. 2019 Apr;180(4):888-893. doi: 10.1111/bjd.17348. Epub 2019 Mar 4. Br J Dermatol. 2019. PMID: 30376179